Paradigm Gold Corporation (TSXV: PDQ) ("Paradigm" or the "Company") has closed the second tranche of its previously announced non-brokered private placement (the "Offering") raising a total of ...

Making Europe great again is now officially a vital interest of the United States. The ambitious policy was codified in the latest National Security Strategy (NSS), which the White House published ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

The YES intervention improved general and cancer-specific quality of life in AYA breast cancer survivors over six months.

Artificial intelligence can enhance decision-making and enable action with reduced risk and greater precision, making it a ...

According to King's College London research, published today in The Lancet Diabetes & Endocrinology, bringing blood glucose ...

First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...

According to King's College London research, published today in The Lancet Diabetes & Endocrinology , bringing blood glucose ...

Recently, a research team led by Professor Xie Huiqi at Sichuan University conducted a systematic review of dual-function biomaterials that combine ...

A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support ...

A mobile health tool used to serially monitor patients through patient-reported outcomes could significantly improve quality ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...